Which has the lower trailing P/E, DXCM or WAT?

DXCM has the lower trailing P/E: DXCM trades at 33.50 and WAT at 101.46. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or WAT?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus WAT at 11.70%.

Is DXCM or WAT more profitable?

DXCM runs the higher net margin — DXCM at 20.12% versus WAT at 3.58%.

How have DXCM and WAT total returns compared?

Over the past 10 years, DXCM delivered 14.02% and WAT delivered 9.97% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs Waters Corporation (WAT)

A side-by-side comparison of DexCom, Inc. and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$33.06B

$87.62HealthcareDelayed quote: Aug 10, 2026, 12:20 PM EDT

WAT

Waters Corporation

$30.68B

$410.20HealthcareDelayed quote: Aug 10, 2026, 12:20 PM EDT

Total return — DXCM vs WAT

growth of $100 · dividends reinvested · last 10y

DXCM +272.0% (+14.0%/yr)WAT +158.4% (+10.0%/yr)DXCM compounded faster over this window

DXCM WAT

DXCM vs WAT: by the numbers

•DXCM is the larger company ($33.06B vs $30.68B market cap).
•DXCM trades at the lower trailing earnings multiple (33.50 vs 101.46 P/E), one valuation lens rather than an overall verdict.
•DXCM converts more revenue to profit (20.12% vs 3.58% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 11.70% CAGR).

Metrics side by side

Valuation

Metric	DXCM	WAT
P/E ratio	33.50	101.46
Forward P/E	31.89	27.93
P/S ratio	6.68	8.60
P/B ratio	12.67	2.63
EV / EBITDA	23.87	47.96
FCF yield	4.23%	0.99%

Profitability

Metric	DXCM	WAT
Gross margin	62.47%	50.78%
Operating margin	22.92%	28.22%
Net margin	20.12%	3.58%
ROE	38.14%	1.09%
ROIC	16.61%	17.57%

Growth (annualized)

Metric	DXCM	WAT
Revenue CAGR (5Y)	18.03%	11.70%
EPS CAGR (5Y)	10.31%	5.16%
FCF CAGR (5Y)	69.49%	-9.19%
Total return CAGR (5Y)	-8.08%	0.57%

Frequently asked

Which has the lower trailing P/E, DXCM or WAT?: DXCM has the lower trailing P/E: DXCM trades at 33.50 and WAT at 101.46. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or WAT?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus WAT at 11.70%.
Is DXCM or WAT more profitable?: DXCM runs the higher net margin — DXCM at 20.12% versus WAT at 3.58%.
How have DXCM and WAT total returns compared?: Over the past 10 years, DXCM delivered 14.02% and WAT delivered 9.97% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full WAT analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio Waters P/E ratio DexCom ROE Waters ROE DexCom operating margin Waters operating margin DexCom revenue growth Waters revenue growth DexCom free cash flow Waters free cash flow

DexCom & Waters appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.